Skip to main content
. 2019 Oct 24;3:PO.19.00086. doi: 10.1200/PO.19.00086

FIG 1.

FIG 1.

Schemas for single integral biomarker-driven trial designs. (A) Enrichment design. (B) Biomarker-stratified design. (C) Biomarker-strategy design. (D) Biomarker-directed design. M-negative, biomarker-negative; M-positive, biomarker-positive; Rx, treatment.